Reed E. Drews

1.6k total citations
43 papers, 1.0k citations indexed

About

Reed E. Drews is a scholar working on Oncology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Reed E. Drews has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Dermatology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Reed E. Drews's work include Cutaneous lymphoproliferative disorders research (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Reed E. Drews is often cited by papers focused on Cutaneous lymphoproliferative disorders research (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Reed E. Drews collaborates with scholars based in United States, Spain and Israel. Reed E. Drews's co-authors include Ellen P. McCarthy, Lisa I. Iezzoni, Steven E. Weinberger, Joanne Lynn, Russell S. Phillips, Zhenshao Zhong, Long Ngo, Richard G. Roetzheim, Marshall E. Kadin and Thomas N. Chirikos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Reed E. Drews

40 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reed E. Drews United States 17 305 232 225 138 131 43 1.0k
Colin Luke Australia 19 381 1.2× 244 1.1× 234 1.0× 88 0.6× 36 0.3× 41 1.1k
Anne‐Sophie Woronoff France 21 578 1.9× 126 0.5× 298 1.3× 156 1.1× 31 0.2× 60 1.2k
K Hieke Germany 13 259 0.8× 87 0.4× 136 0.6× 142 1.0× 147 1.1× 23 1.3k
Benjamin Chastek United States 17 187 0.6× 168 0.7× 112 0.5× 119 0.9× 28 0.2× 60 910
Urshila Durani United States 15 220 0.7× 233 1.0× 93 0.4× 47 0.3× 55 0.4× 63 765
Thomas Mittendorf Germany 23 161 0.5× 146 0.6× 308 1.4× 99 0.7× 26 0.2× 105 1.7k
Alexandre L. Pavluck United States 18 737 2.4× 238 1.0× 250 1.1× 111 0.8× 26 0.2× 39 1.6k
C S Thomson United Kingdom 20 932 3.1× 188 0.8× 203 0.9× 174 1.3× 81 0.6× 38 1.6k
Fiona L. Dignan United Kingdom 22 342 1.1× 293 1.3× 191 0.8× 72 0.5× 76 0.6× 38 1.8k
Kevin Y. Kane United States 9 498 1.6× 138 0.6× 64 0.3× 149 1.1× 72 0.5× 15 1.0k

Countries citing papers authored by Reed E. Drews

Since Specialization
Citations

This map shows the geographic impact of Reed E. Drews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reed E. Drews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reed E. Drews more than expected).

Fields of papers citing papers by Reed E. Drews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reed E. Drews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reed E. Drews. The network helps show where Reed E. Drews may publish in the future.

Co-authorship network of co-authors of Reed E. Drews

This figure shows the co-authorship network connecting the top 25 collaborators of Reed E. Drews. A scholar is included among the top collaborators of Reed E. Drews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reed E. Drews. Reed E. Drews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Miller, David M., Vernon K. Sondak, Sunandana Chandra, et al.. (2025). Dual Checkpoint Blockade in Merkel Cell Carcinoma: Lessons from CheckMate 358 and the Questions That Remain. 3(1).
3.
Drews, Reed E., et al.. (2024). Novel uses of complement inhibitors in myasthenia gravis—Two case reports. Muscle & Nerve. 69(3). 368–372. 10 indexed citations
4.
Drews, Reed E., Marc Zumberg, Leslie R. Ellis, et al.. (2023). Consensus recommendations on peripheral blood smear review: defining curricular standards and fellow competency. Blood Advances. 7(13). 3244–3252. 2 indexed citations
5.
Roberts, Daniel A., K. Leahy, Sara Giordano, et al.. (2022). Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the Future. JCO Oncology Practice. 19(6). e927–e934. 5 indexed citations
6.
Storino, Alessandra, Reed E. Drews, & Nicholas E. Tawa. (2021). Malignant Cutaneous Adnexal Tumors and Role of SLNB. Journal of the American College of Surgeons. 232(6). 889–898. 10 indexed citations
7.
Batalini, Felipe, et al.. (2019). Temozolomide-induced aplastic anaemia and incidental low-grade B-cell non-Hodgkin lymphoma in a geriatric patient with glioblastoma multiforme. BMJ Case Reports. 12(6). e228803–e228803. 3 indexed citations
9.
Miller, David M., Beverly E. Faulkner-Jones, James R. Stone, & Reed E. Drews. (2017). Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade. JAAD Case Reports. 3(5). 412–415. 39 indexed citations
10.
Roetzheim, Richard G., Thomas N. Chirikos, Kristen J. Wells, et al.. (2008). Managed care and cancer outcomes for Medicare beneficiaries with disabilities.. PubMed. 14(5). 287–96. 10 indexed citations
11.
Iezzoni, Lisa I., Long Ngo, Donglin Li, et al.. (2008). Early Stage Breast Cancer Treatments for Younger Medicare Beneficiaries with Different Disabilities. Health Services Research. 43(5p1). 1752–1767. 30 indexed citations
12.
McCarthy, Ellen P., Long Ngo, Thomas N. Chirikos, et al.. (2006). Cancer Stage at Diagnosis and Survival among Persons with Social Security Disability Insurance on Medicare. Health Services Research. 42(2). 611–628. 44 indexed citations
13.
Vandendries, Erik & Reed E. Drews. (2006). Drug-Associated Disease: Hematologic Dysfunction. Critical Care Clinics. 22(2). 347–355. 17 indexed citations
14.
Adams, Amy E., Jeffrey I. Zwicker, Marshall E. Kadin, et al.. (2004). Aggressive cutaneous T-cell lymphomas after TNFα blockade. Journal of the American Academy of Dermatology. 51(4). 660–662. 71 indexed citations
15.
Drews, Reed E.. (2003). Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clinics in Chest Medicine. 24(4). 607–622. 89 indexed citations
16.
Drews, Reed E. & Steven E. Weinberger. (2000). Thrombocytopenic Disorders in Critically Ill Patients. American Journal of Respiratory and Critical Care Medicine. 162(2). 347–351. 82 indexed citations
17.
McCarthy, Ellen P., Russell S. Phillips, Zhenshao Zhong, Reed E. Drews, & Joanne Lynn. (2000). Dying with Cancer: Patients' Function, Symptoms, and Care Preferences as Death Approaches. Journal of the American Geriatrics Society. 48(S1). S110–21. 187 indexed citations
18.
Drews, Reed E., et al.. (1998). Genetic analysis of adenovirus E1A: induction of genetic instability and altered cell morphologic and growth characteristics are segregatable functions. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 421(1). 9–25. 4 indexed citations
20.
Iezzoni, Lisa I., et al.. (1991). Purpose of admission and resource use during cancer hospitalizations.. PubMed. 13(2). 29–40. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026